258 related articles for article (PubMed ID: 1519576)
1. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
Khasawneh SM; Affarah HB
Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
Young MD; Lottes SR; Webb LA
Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
4. [Prospective study of duodenal ulcer. Analysis of prognostic factors].
Guerreiro S; Neves B; Va S; Pires M; Gouveia A; Quina M
Acta Med Port; 1991; 4(4):191-7. PubMed ID: 1767711
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcers.
Bank S; Greenberg RE; Magier D; Lavin PT
Clin Ther; 1991; 13(2):304-18. PubMed ID: 1863945
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
8. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Delvaux M; Hagège CG; Ribet A
Gastroenterol Clin Biol; 1989 Dec; 13(12):1055-9. PubMed ID: 2696659
[TBL] [Abstract][Full Text] [Related]
9. Is the inhibition of nocturnal gastric acid secretion the most important factor in duodenal ulcer treatment? A comparison between the effectiveness of single morning and nocte doses of ranitidine 300 mg.
Zaterka S; Massuda HK; Eisig JN; Chinzon D; Bettarello A
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):185-8. PubMed ID: 2700103
[TBL] [Abstract][Full Text] [Related]
10. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
Alcalá Santaella R; Guardia J; Pajares J; Pique J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
[TBL] [Abstract][Full Text] [Related]
12. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
14. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of twice a day versus once a day cimetidine therapy for duodenal ulcer.
Aggarwal R; Kochhar R; Gupta BB; Goenka MK; Mehta SK
J Assoc Physicians India; 1990 Dec; 38(12):917-8. PubMed ID: 2096128
[TBL] [Abstract][Full Text] [Related]
16. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
17. Duodenal ulcer in the Sudan. Clinical features and treatment with H2 blockers.
Ahmed M el-B ; Arbab BM; Homeida MM
Trop Geogr Med; 1993; 45(6):287-9. PubMed ID: 8116060
[TBL] [Abstract][Full Text] [Related]
18. Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment.
Savarino V; Mela GS; Zentilin P; Cutela P; Mansi C; Vassallo A; Franceschi M; Mela MR; Dallorto E; Celle G
Am J Gastroenterol; 1993 Jul; 88(7):1088-92. PubMed ID: 8317411
[TBL] [Abstract][Full Text] [Related]
19. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
20. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
de Gara CJ; Burget DW; Silletti C; Hunt RH
Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
